Post Profile

More than half of persons with Alzheimer's disease aged 90 years or more use psychotropic drugs

(University of Eastern Finland) Psychotropic drug use is rather common among persons aged 90 years of more diagnosed with Alzheimer's disease compared with those who were diagnosed at younger age, concludes study conducted at University of Eastern Finland. Persons aged 90 years or more used antipsychotics 5 times and antidepressants 2.5 times more often than those without the disease in the same age group.
read more


Related Posts

Researchers Study Mitochondrial Function, Potential New Therapeutic Target for Alzheimer's Disease

Health : Newswise Medical News

Researchers at Rush University Medical Center are conducting an early phase clinical trial of a novel drug therapy for patients with dementia due to Alzheimer's disease. The drug is a new compound called MSDC-0160, which is an insul...

Antidepressant use begins years before Alzheimer's diagnosis

Academics / General Science : Science Codex

Antidepressants are frequently initiated in persons with Alzheimer's disease already before the diagnosis, shows a recent study from the University of Eastern Finland. Among persons with Alzheimer's disease, the initiation of antide...

Diabetes drug enters clinical trial for Alzheimer's treatment

Health : Medical News Today

A drug commonly used for treating diabetes may reverse symptoms of late-stage Alzheimer's disease and is now in the process of entering a major clinical trial. Researchers from Lancaster University in the UK conducted a study reveal...

Inappropriate Psychotropics Are More Often Used By Elderly With Low Income

Health : Medical News Today

Elderly persons often have several diseases and use many drugs; they are also more sensitive to drugs compared to younger persons. Use of more drugs than necessary tends to occur among the elderly, however, underuse of drugs and use...

Alzheimer's Drugs Prove Elusive, But Big Pharma Hasn't Lost Interest

Technology : News Week: Technology and Science

This article originally appeared on the Motley Fool. Alzheimer's disease has been a graveyard for experimental medications. A recent study, for instance, reported that a whopping 99.6 percentĀ of experimental Alzheimer's drugsĀ failed...


Copyright © 2016 Regator, LLC